Rating History for Ascendis Pharma (ASND) by Raymond James
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/15/2026 | Martin Auster | Downgrade | Outperform (Strong Buy) |
287.00 (N/A) |
263.51 (225.25) |
-14.52% | Details |
 |
|||||||
